-
COVID-19 has led to the suspension of many clinical studies of experimental treatments. About a quarter of the stopped trials involved new cancer treatments, an NPR analysis finds.
-
The aim is to make clinical trial data available to volunteers and scientists, even if a drug or therapy being tested turns out to be a failure. That could help identify serious side effects.